|Articles|October 1, 2012
- Pharmaceutical Executive-10-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - October 2012
Lundbeck's Big Bet
Advertisement
Articles in this issue
almost 14 years ago
PE, October 2012 Cover Imagealmost 14 years ago
Lundbeck: Bidding for the Stars and Stripesalmost 14 years ago
The Drug Vote 2012almost 14 years ago
Your Local Competitor: A Threat in Emerging Markets?almost 14 years ago
Reforming Pharma Marketingalmost 14 years ago
Three Ways to the Futurealmost 14 years ago
Country Report: Turkeyalmost 14 years ago
Stem Cells: A Promise Deferred?almost 14 years ago
Richard Bergström — Europe's Medicine ManAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes
3
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
4
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
5